RT @MCT_AACR: Attending the Drug Resistance: Challenges and Prospects educational session at #AACR22? Check out this #FirstDisclosure paper…
4,156 followers
1,319 followers
Attending the Drug Resistance: Challenges and Prospects educational session at #AACR22? Check out this #FirstDisclosure paper on TPX-0131, a next-generation ALK inhibitor that targets an array of ALK resistance mutations including G1202R. https://t.co/gdCx
15 followers
RT @MCT_AACR: Preclinical studies show that TPX-0131 is a CNS-penetrant, next-generation ALK inhibitor with potency against wild-type ALK a…
486 followers
RT @MCT_AACR: Preclinical studies show that TPX-0131 is a CNS-penetrant, next-generation ALK inhibitor with potency against wild-type ALK a…